The U.S. CDC's Advisory Committee on Immunization Practices (ACIP) underwent contentious discussions regarding the recommendation to delay the hepatitis B birth dose in certain newborns and to remove the MMRV combination vaccine for children under 4. These votes, postponed or passed amid political and scientific scrutiny following committee recasting by Robert F. Kennedy Jr., have raised concerns about potential impacts on childhood vaccination coverage and public health outcomes.